| CIRC_0003907 MODULATES SEPSIS-INDUCED MYOCARDIAL INJURY VIA ENHANCING MYD88/NLRP3/NF-KappaB AXIS BY SPONGING MIR-944. | CIRC_0003907 MODULATES SEPSIS-INDUCED MYOCARDIAL INJURY VIA ENHANCING MYD88/NLRP3/NF-ΚB AXIS BY SPONGING MIR-944.
Lv W, Liu H, Wang X, Hao R. | 05/10/2024 |
| Investigation of miR-133a, miR-637 and miR-944 genes expression and their relationship with PI3K/AKT signaling in women with breast cancer. | Investigation of miR-133a, miR-637 and miR-944 genes expression and their relationship with PI3K/AKT signaling in women with breast cancer.
Barartabar Z, Moini N, Abbasalipourkabir R, Mesbah-Namin SA, Ziamajidi N. | 07/27/2023 |
| Circulating microRNA-944 and its target gene EPHA7 as a potential biomarker for colorectal cancer. | Circulating microRNA-944 and its target gene EPHA7 as a potential biomarker for colorectal cancer.
Shaker OG, Ayeldeen G, Abdelhamid AM. | 10/8/2022 |
| LncRNA LEMD1-AS1 relieves chondrocyte inflammation by targeting miR-944/PGAP1 in osteoarthritis. | LncRNA LEMD1-AS1 relieves chondrocyte inflammation by targeting miR-944/PGAP1 in osteoarthritis.
Li H, Lian K, Mao J, Huang F, Zhang C, Zang J., Free PMC Article | 09/17/2022 |
| LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944. | LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944.
Mao D, Jie Y, Lv Y., Free PMC Article | 05/21/2022 |
| Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling. | Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
Jiang J, Lu J, Wang X, Sun B, Liu X, Ding Y, Gao G., Free PMC Article | 01/15/2022 |
| Long Noncoding RNA LINC00899/miR-944/ESR1 Axis Regulates Cervical Cancer Cell Proliferation, Migration, and Invasion. | Long Noncoding RNA LINC00899/miR-944/ESR1 Axis Regulates Cervical Cancer Cell Proliferation, Migration, and Invasion.
Chen Y, Gu Y, Gu Y, Wu J. | 01/15/2022 |
| MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking. | MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking.
Peng HY, Hsiao JR, Chou ST, Hsu YM, Wu GH, Shieh YS, Shiah SG., Free PMC Article | 07/31/2021 |
| Synergetic Effects of Intronic Mature miR-944 and DeltaNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line. | Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.
Kim J, Park S, Chang Y, Park KH, Lee H., Free PMC Article | 02/20/2021 |
| Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. | Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q, Liu GS, Li HP, Zhang Y, Xu XC, Gao H, Zhang W, Li T. | 10/24/2020 |
| miR-944 is structurally combined with GATA6 and interacts with downstream proteins (CRT and p-AKT) in colorectal cells. | Ectopic expression of miR-944 impairs colorectal cancer cell proliferation and invasion by targeting GATA binding protein 6.
Tang JT, Zhao J, Sheng W, Zhou JP, Dong Q, Dong M., Free PMC Article | 07/18/2020 |
| The overexpression of miR-944 caused G1 phase arrest and increased p53 expression in cancer cells. p53 stability was enhanced by miR-944s targeting E3 ligases COP1 and MDM2. Overexpression of COP1 and MDM2 restored cell growth inhibition caused by miR-944. | Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.
Kim YJ, Lee JH, Jin S, Kim JH, Kim SH. | 10/12/2019 |
| The expression levels of miR-944 in cervical cancer tissues were significantly higher compared with normal tissues. Expression levels of miR-944 in cervical cancer cell lines and tissues with human papillomavirus (HPV) infection were significantly higher compared to those without HPV infection. High miR-944 expression group showed shorter overall survival than the low miR-944 expression group in the advanced FIGO stage. | microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S, Kim J, Eom K, Oh S, Kim S, Kim G, Ahn S, Park KH, Chung D, Lee H., Free PMC Article | 09/14/2019 |
| miR-944 was significantly downregulated in cancer tissues and cell lines. Upregulating miR-944 inhibited cellular proliferation and invasion in OS cells by directly targeting VEGF. | MicroRNA‑944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma.
Yan T, Zhu S, Zhang J, Lu G, Lv C, Wei Y, Luo M. | 02/2/2019 |
| that pri-miRNA-944 and miRNA-944 may be involved in early squamous-type differentiation of lung tumors | Investigation of relationship between precursor of miRNA-944 and its mature form in lung squamous-cell carcinoma - the diagnostic value.
Powrózek T, Mlak R, Dziedzic M, Małecka-Massalska T, Sagan D. | 09/8/2018 |
| restoration of MACC1 expression could abrogate the anti-metastatic effects of miR-944 on colorectal cancer (CRC)cells with enhanced cell migration and invasion. MACC1/Met/AKT signaling may be implicated with the function of miR-944 in CRC cells. Altogether, miR-944 potentially act as a prognostic predictor and a drug-target for CRC patients. | miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer.
Wen L, Li Y, Jiang Z, Zhang Y, Yang B, Han F. | 03/3/2018 |
| Results showed that miR-944 is a novel upstream negative regulator of SIAH1 and PTP4A1 genes and provided evidence for its functional role in migration and invasion of breast cancer cells. | Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells.
Flores-Pérez A, Marchat LA, Rodríguez-Cuevas S, Bautista VP, Fuentes-Mera L, Romero-Zamora D, Maciel-Dominguez A, de la Cruz OH, Fonseca-Sánchez M, Ruíz-García E, la Vega HA, López-Camarillo C., Free PMC Article | 10/21/2017 |
| miR-944 can be potentially used as a promising biomarker and novel therapeutic target for human endometrial cancer. | miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z, Xu H, Meng Y, Kuang Y. | 03/18/2017 |
| our study showed that miR-944 functions as a novel oncogene and regulates the cisplatin resistance in breast cancer | MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.
He H, Tian W, Chen H, Jiang K. | 01/28/2017 |
| The findings suggested that miR-944, as an intronic miRNA and a direct target of DeltaNp63, contributes to the function of DeltaNp63 in the induction of epidermal differentiation. | ΔNp63 intronic miR-944 is implicated in the ΔNp63-mediated induction of epidermal differentiation.
Kim KH, Cho EG, Yu SJ, Kang H, Kim YJ, Kim SH, Lee TR., Free PMC Article | 12/19/2015 |
| Expression of miR-944 and miR-3662 was upregulated in patients with lung cancer in comparison with healthy individuals. | Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
Powrózek T, Krawczyk P, Kowalski DM, Winiarczyk K, Olszyna-Serementa M, Milanowski J. | 12/12/2015 |
| High miR-944 expression is associated with cervical cancer. | Novel functions and targets of miR-944 in human cervical cancer cells.
Xie H, Lee L, Scicluna P, Kavak E, Larsson C, Sandberg R, Lui WO., Free PMC Article | 02/28/2015 |